Monitoring: Frequent initial follow-ups (surgeon's schedule, typically daily to weekly first month), objective healing markers (corneal clarity, retinal reattachment, vision recovery), reduce intensity as healing progresses
(Small-scale compounding with prescriber-signed Rx is still technically allowed under Section 503A, but few physicians risk it.) 7.4 Impact on GLP-1 Brands The combined effect of these barriers is that brand uptake data often fall short of forecasts
Visual Inspection Before each use, inspect for: Changes in solution color Cloudiness or particulate matter Any abnormal smell Timeline Monitoring Track: Date of first use Manufacturer expiration date Cumulative storage conditions Documenting use and checking vials regularly helps ensure medication quality is maintained
Ozempic and other GLP-1 receptor agonists dampen mesolimbic dopamine signaling, reducing reward salience and drug reinforcement across addictions
Notably, several patient advocacy groups from India were among the first in the world to approach the WHO in 2024, seeking the inclusion of GLP-1 drugs for diabetes in the organizations Essential Medicines List (EML)